BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8895988)

  • 21. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.
    Rebbeck TR; Wang Y; Kantoff PW; Krithivas K; Neuhausen SL; Godwin AK; Daly MB; Narod SA; Brunet JS; Vesprini D; Garber JE; Lynch HT; Weber BL; Brown M
    Cancer Res; 2001 Jul; 61(14):5420-4. PubMed ID: 11454686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan.
    Iwasaki M; Otani T; Inoue M; Sasazuki S; Tsugane S;
    Eur J Cancer Prev; 2007 Apr; 16(2):116-23. PubMed ID: 17297387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular genetics of hereditary breast carcinoma].
    Hampl M; Chang-Claude J; Schwarz P; Saeger HD; Schackert HK
    Zentralbl Chir; 1997; 122(2):67-73. PubMed ID: 9173760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
    Anderson WF; Matsuno RK; Sherman ME; Lissowska J; Gail MH; Brinton LA; Yang XR; Peplonska B; Chen BE; Rosenberg PS; Chatterjee N; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Devesa SS; García-Closas M
    Cancer Causes Control; 2007 May; 18(4):439-47. PubMed ID: 17216325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case-control study of risk factors of breast cancer detected by mass screening].
    Tashiro H; Nomura Y; Hisamatu K
    Gan No Rinsho; 1990 Oct; 36(12):2127-30. PubMed ID: 2232181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited susceptibility to breast cancer.
    Easton D; Ford D; Peto J
    Cancer Surv; 1993; 18():95-113. PubMed ID: 8013003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous estrogens and other factors in the epidemiology of breast cancer.
    Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
    J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer.
    Sellers TA; Kushi LH; Potter JD; Kaye SA; Nelson CL; McGovern PG; Folsom AR
    N Engl J Med; 1992 May; 326(20):1323-9. PubMed ID: 1565145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial risk of breast cancer in a French case-control study.
    Andrieu N; Clavel F; Gairard B; Piana L; Brémond A; Lansac J; Flamant R; Renaud R
    Cancer Detect Prev; 1994; 18(3):163-9. PubMed ID: 8076378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of breast cancer].
    Ebeling K; Nischan P
    Arch Geschwulstforsch; 1988; 58(3):197-212. PubMed ID: 3046556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
    Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
    J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of breast cancer in a screened population.
    Dubin N; Pasternack BS; Strax P
    Cancer Detect Prev; 1984; 7(2):87-102. PubMed ID: 6713446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer risk factors among screening program participants.
    Brinton LA; Williams RR; Hoover RN; Stegens NL; Feinleib M; Fraumeni JF
    J Natl Cancer Inst; 1979 Jan; 62(1):37-44. PubMed ID: 281576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiologic characteristics of breast cancer in three menopausal stages: preliminary findings.
    Paffenbarger RS; Greenberg LM; Chang HG; Kampert JB
    Natl Cancer Inst Monogr; 1979 Nov; (53):195-202. PubMed ID: 537627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors of breast cancer among women in Tianjin, China and Adelaide, Australia].
    Zhang AY
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):437-40. PubMed ID: 3250829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis.
    King MC; Go RC; Lynch HT; Elston RC; Terasaki PI; Petrakis NL; Rodgers GC; Lattanzio D; Bailey-Wilson J
    J Natl Cancer Inst; 1983 Sep; 71(3):463-7. PubMed ID: 6577221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of the history in the office diagnosis of breast cancer.
    Devitt JE
    Can Med Assoc J; 1977 May; 116(10):1127-8. PubMed ID: 861861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for germ line TP53 mutations in breast cancer patients.
    Børresen AL; Andersen TI; Garber J; Barbier-Piraux N; Thorlacius S; Eyfjörd J; Ottestad L; Smith-Sørensen B; Hovig E; Malkin D
    Cancer Res; 1992 Jun; 52(11):3234-6. PubMed ID: 1591732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.